Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. lessened its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 33.4% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 142,056 shares of the company's stock after selling 71,099 shares during the period. Harbor Capital Advisors Inc. owned 0.09% of Option Care Health worth $4,965,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its stake in Option Care Health by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after purchasing an additional 344,875 shares in the last quarter. MetLife Investment Management LLC increased its stake in shares of Option Care Health by 7.8% during the fourth quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock worth $4,575,000 after buying an additional 14,311 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Option Care Health by 6.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after purchasing an additional 147,054 shares in the last quarter. Global Alpha Capital Management Ltd. lifted its holdings in Option Care Health by 38.1% during the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock worth $1,596,000 after buying an additional 18,992 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in Option Care Health during the fourth quarter worth approximately $327,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

OPCH has been the subject of several research analyst reports. Barrington Research restated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. JMP Securities reissued a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Stock Performance

OPCH traded down $0.27 on Friday, hitting $31.60. 1,119,035 shares of the company traded hands, compared to its average volume of 1,935,371. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a 50 day moving average of $32.24 and a 200-day moving average of $30.21. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.17 billion, a PE ratio of 26.55, a PEG ratio of 2.30 and a beta of 0.74.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same quarter in the previous year, the company posted $0.26 earnings per share. The company's revenue for the quarter was up 16.3% compared to the same quarter last year. Sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.